Subscribe

Jerel A. Banks, MD, PhD

The executive chairman and CEO of Benitec Biopharma

Articles by Jerel A. Banks, MD, PhD

Jerel A. Banks, MD, PhD, the CEO of Benitec Biopharma

Evaluating Gene Therapy BB-301 for OPMD-Related Dysphagia

ByJerel A. Banks, MD, PhD,Noah Stansfield

April 19th 2026

Jerel A. Banks, MD, PhD, the CEO of Benitec Biopharma, discussed data he presented at MDA's 2026 conference.

Jerel A. Banks, MD, PhD, CEO and chairman of the board of Benitec Biopharma

Jerel A. Banks, MD, PhD, on Evaluating Gene Therapy BB-301 for OPMD-Related Dysphagia

ByJerel A. Banks, MD, PhD,Noah Stansfield

March 13th 2026

The CEO of Benitec Biopharma discussed data he presented at MDA's 2026 conference.

Latest Updated Articles

Evaluating Gene Therapy BB-301 for OPMD-Related Dysphagia
April 19th 2026

Trending on CGTlive®

Aspen Neuroscience Completes ASPIRO Cohort 3 and 4 Dosing, Advancing Sasineprocel Toward Phase 3